Recommendations for diagnosis and treatment of ankylosing spondylitis
10.3760/cma.j.cn112138-20211226-00913
- VernacularTitle:强直性脊柱炎诊疗规范
- Author:
Feng HUANG
1
;
Jian ZHU
;
Yuhua WANG
;
Jianglin ZHANG
;
Hongtao JIN
;
Wen ZHANG
;
Yin SU
;
Yan ZHAO
Author Information
1. 解放军总医院第一医学中心风湿免疫科，北京100853
- Keywords:
Spondylitis, ankylosing;
Diagnosis;
Treatment
- From:
Chinese Journal of Internal Medicine
2022;61(8):893-900
- CountryChina
- Language:Chinese
-
Abstract:
Ankylosing spondylitis (AS) is a chronic inflammatory disease mainly affecting the sacroiliac joints, spine and peripheral joints. In China, standardized diagnosis and treatment of AS is still to be popularized. Based on the evidence and guidelines from China and other countries, Chinese Rheumatology Association developed standardization of diagnosis and treatment of AS. The purposes are: (1) to standardize the diagnosis and evaluation of AS; (2) to promote rational use of non-steroidal anti-inflammatory drugs, biological as well as traditional disease modifying anti-rheumatic drugs, so as to improve the patient′s quality of life.
